Medication-Assisted Treatment (MAT) Delivery

This contract involves the delivery of Medication-Assisted Treatment (MAT) for opioid use disorder through the prescribing, dispensing, and monitoring of FDA-approved medications such as buprenorphine, methadone, and naltrexone. The service is intended to be integrated into comprehensive outpatient opioid treatment programs, aiming to support individuals in their recovery process. It is issued by the Community Services Board in Virginia and categorized under the NAICS code 621420, which corresponds to outpatient mental health and substance abuse centers. The contract is a subcontract opportunity with a response deadline set for May 19, 2026. Specific details about the location of performance, point of contact, and any set-aside status are not provided. The solicitation emphasizes the importance of adhering to FDA guidelines for medication management within a comprehensive treatment framework, highlighting a focus on quality and continuity of care for individuals dealing with opioid addiction.